Safety considerations with combination therapies for psoriasis

被引:19
作者
Nakamura, Mio [1 ]
Koo, John [2 ]
机构
[1] Univ Michigan, Dept Dermatol, 1910 Taubman Ctr,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA
[2] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
关键词
Psoriasis; safety; combination therapy; rotational therapy; sequential therapy; phototherapy; systemic therapy; biologics; ULTRAVIOLET-B PHOTOTHERAPY; TOPICAL CORTICOSTEROIDS USEFUL; PROPIONATE SPRAY 0.05-PERCENT; CONTACT ANTHRALIN THERAPY; CHRONIC PLAQUE PSORIASIS; MU-G/G; UVB PHOTOTHERAPY; DOUBLE-BLIND; CALCIPOTRIENE OINTMENT; TREATMENT REGIMEN;
D O I
10.1080/14740338.2020.1722640
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Psoriasis is a chronic inflammatory skin disease that waxes and wanes, and long-term remission can be difficult to achieve regardless of disease severity. Currently, numerous treatment options are available for psoriasis including steroid and non-steroid topical agents, phototherapy, oral systemic agents, and biologics, with many more therapeutic agents under development. Areas covered: This article will review various combination therapy strategies such as rotational therapy and sequential therapy and describe a variety of safe and effective combination therapies for the treatment of psoriasis. Two or more agents with different mechanisms of action and safety profiles can be used to achieve and/or maintain adequate disease control while minimizing the toxicity of treatments. Combination therapy can also be used when a single agent is not enough for treating recalcitrant disease. Choosing a combination regimen that maximizes safety and efficacy while considering patient usability and compliance can be a challenge. Expert opinion: Given the various treatment options currently available for psoriasis and more agents under development, combination therapy will continue to be a valuable treatment strategy for any patient with psoriasis. It is crucial for clinicians to carefully consider the fine balance between safety and efficacy when combining various therapeutic agents.
引用
收藏
页码:489 / 498
页数:10
相关论文
共 116 条
  • [91] Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study
    Paul, CF
    Ho, VC
    McGeown, C
    Christophers, E
    Schmidtmann, B
    Guillaume, JC
    Lamarque, V
    Dubertret, L
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (02) : 211 - 216
  • [92] TOPICAL STEROIDS AND UV-RADIATION IN PSORIASIS
    PETROZZI, JW
    [J]. ARCHIVES OF DERMATOLOGY, 1983, 119 (03) : 207 - 210
  • [93] Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases
    Philipp, Sandra
    Wilsmann-Theis, Dagmar
    Weyergraf, Ansgar
    Rotterdam, Sebastian
    Frambach, Yvonne
    Gerdes, Sascha
    Moessner, Rotraut
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (11): : 821 - 838
  • [94] Positive effect of using calcipotriol ointment with narrow-band ultraviolet B phototherapy in psoriatic patients
    Rim, JH
    Choe, YB
    Youn, JI
    [J]. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2002, 18 (03) : 131 - 134
  • [95] Calcitriol 3 μg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis:: results of a comparative study
    Ring, J
    Kowalzick, L
    Christophers, E
    Schill, WB
    Schöpf, E
    Ständer, M
    Wolff, HH
    Altmeyer, P
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (03) : 495 - 499
  • [96] Rothstein BE, 2016, J DRUGS DERMATOL, V15, P648
  • [97] EFFICIENCY OF ACITRETIN IN COMBINATION WITH UV-B IN THE TREATMENT OF SEVERE PSORIASIS
    RUZICKA, T
    SOMMERBURG, C
    BRAUNFALCO, O
    KOSTER, W
    LENGEN, W
    LENSING, W
    LETZEL, H
    MEIGEL, WN
    PAUL, E
    PRZYBILLA, B
    STEINERT, M
    WINZER, M
    WISKEMANN, A
    [J]. ARCHIVES OF DERMATOLOGY, 1990, 126 (04) : 482 - 486
  • [98] Combination therapy of apremilast and secukinumab in patients with moderate-to-severe, recalcitrant plaque psoriasis
    Sacchelli, L.
    Patrizi, A.
    Loi, C.
    Bardazzi, F.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (07) : E243 - E244
  • [99] Sasaki J, 2016, J PSORIASIS PSORIATI, V1, P70
  • [100] RANDOMIZED DOUBLE-BLIND MULTICENTER STUDY COMPARING ACITRETIN-PUVA, ETRETINATE-PUVA AND PLACEBO-PUVA IN THE TREATMENT OF SEVERE PSORIASIS
    SAURAT, JH
    GEIGER, JM
    AMBLARD, P
    BEANI, JC
    BOULANGER, A
    CLAUDY, A
    FRENK, E
    GUILHOU, JJ
    GROSSHANS, E
    MEROT, Y
    MEYNADIER, J
    TAPERNOUX, B
    [J]. DERMATOLOGICA, 1988, 177 (04): : 218 - 224